Skip to main content
Smart Investors Daily
VT

OTC · VTRLY

Vitrolife AB (publ)

Healthcare · Medical - Devices

$9.50

Up+$0.00 (+0.00%)

Updated Aug 27, 2026, 6:45 PM

SID Score

4.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
2.1B
P/E ratio
42.84
Dividend yield
1.20%
52-week range
— – —
Volume
289
Avg. volume
53

Price performance

VTRLY price history

1M range · 0 trading sessions · Daily adjusted prices

VTRLY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest VTRLY news

The latest Smart Investors Daily articles mentioning VTRLY.

VTRLY research

Overview

Company profile and research snapshot.

Company profile

VITROLIFE AB UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
VTRLY recent ratings
DateFirmRatingTarget
Jul 7, 2026HANDELSBANKEN CAPITAL MARKETSHold
Jun 29, 2026DNB CARNEGIEBuy
Jun 28, 2026PARETO SECURITIES ASHold
Apr 6, 2026PARETO SECURITIES ASBuy
Jan 21, 2026HANDELSBANKEN CAPITAL MARKETSHold
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 17, 2026

European Stocks That May Be Trading Below Their Estimated Value In February 2026

As European markets experience volatility amid concerns about AI disruption and digest strong U.S. job data, the pan-European STOXX Europe 600 Index has reached new highs but remains largely unchanged. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.